The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Increased levels of stromelysin‐1 and tissue inhibitor of metalloproteinases–1 in sera from patients with rheumatoid arthritis
Abstract
Objective. To evaluate the efficacy of stromelysin‐1 (matrix metalloproteinase–3 [MMP‐3]) and tissue inhibitor of metalloproteinases–1 (TIMP‐1) in serum as markers for joint inflammation in rheumatoid arthritis (RA). Methods. Levels of both macromolecules in sera from 97 healthy controls, 109 patients with RA, and 47 patients with osteoarthritis (OA) were measured by respective 1‐step sandwich enzyme immunoassays. In the patients with RA, serum levels of MMP‐3 and TIMP‐1 were investigated in relation to laboratory and clinical measures of disease activity. In addition, the relationships between serum and synovial fluid (SF) levels in paired samples from individual patients were examined. Results. Serum levels of both MMP‐3 and TIMP‐1 in RA patients were significantly higher than those in OA patients and in healthy controls (P < 0.001), and were shown to correlate with traditional systemic markers of inflammation including the erythrocyte sedimentation rate and C‐reactive protein level, and with the Lansbury articular index. In addition, it was noted that serum levels of MMP‐3 correlated with the corresponding values in paired SF samples obtained concurrently from patients with RA (r s = 0.588, P < 0.001), while such correlations were not found for TIMP‐1 levels. Conclusion. Our results support the notion that levels of both MMP‐3 and TIMP‐1 in RA patient sera are increased in association with inflammation. Furthermore, the level of MMP‐3 in serum provides a particularly useful marker of inflammatory activity in the joints of patients with RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Madhok, R., Crilly, A., Watson, J., & Capell, H. A. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.3.232 · Cited by 340
Cited by
Schönbeck, U., Mach, F., & Libby, P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3340 · Cited by 595
Yoshihara, Y., Nakamura, H., Obata, K., Yamada, H., Hayakawa, T., Fujikawa, K., & Okada, Y. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.6.455 · Cited by 565
Self-citationMatrix metalloproteinase inhibitors
Wojtowicz-Praga, S. M., Dickson, R. B., & Hawkins, M. J. (1997) · Investigational New Drugs · doi:10.1023/a:1005722729132 · Cited by 518
Autoimmunity and oxidatively modified autoantigens
Kurien, B. T., & Scofield, R. H. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.04.019 · Cited by 268
Hao, H. Q., Zhang, J. F., He, Q. Q., & Wang, Z. (2019) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2018.10.009 · Cited by 118
Metadata
- Authors
- Yoshihara, Y., Obata, K., Fujimot, N., Yamashita, K., Hayakawa, T., & Shimmei, M.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1995-07
- Volume
- 38
- Issue
- 7
- Pages
- 969-975
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2093521383
- Cited by
- 161
- References
- 1
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased levels of stromelysin‐1 and tissue inhibitor of metalloproteinases–1 in sera from patients with rheumatoid arthritis. https://app.cochat.ai/papers/10.1002/art.1780380713
- The paper
- Yoshihara, Y., Obata, K., Fujimot, N., Yamashita, K., Hayakawa, T., & Shimmei, M. (1995). Increased levels of stromelysin‐1 and tissue inhibitor of metalloproteinases–1 in sera from patients with rheumatoid arthritis. Arthritis & Rheumatism. https://doi.org/10.1002/art.1780380713
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.